Payment Breakdown by Category
Payments by Nature
| Nature of Payment | Amount | Transactions | Share |
|---|---|---|---|
| Food and Beverage | $43.33 | 3 | 100.0% |
Top Paying Companies
| Company | Total | Records | Latest Year |
|---|---|---|---|
| Teva Pharmaceuticals USA, Inc. | $26.06 | 2 | $0 (2017) |
| Indivior Inc. | $17.27 | 1 | $0 (2017) |
Payment History by Year
| Year | Amount | Transactions | Top Company |
|---|---|---|---|
| 2017 | $43.33 | 3 | Teva Pharmaceuticals USA, Inc. ($26.06) |
All Payment Transactions
3 individual payment records from CMS Open Payments
| Date | Company | Product | Nature | Form | Amount | Type |
|---|---|---|---|---|---|---|
| 03/27/2017 | Indivior Inc. | SUBOXONE SUBLINGUAL FILM (Drug) | Food and Beverage | Cash or cash equivalent | $17.27 | General |
| Category: OUD | ||||||
| 01/09/2017 | Teva Pharmaceuticals USA, Inc. | PROAIR (Drug) | Food and Beverage | In-kind items and services | $13.03 | General |
| Category: Respiratory | ||||||
| 01/09/2017 | Teva Pharmaceuticals USA, Inc. | PROAIR (Drug) | Food and Beverage | In-kind items and services | $13.03 | General |
| Category: Respiratory | ||||||
Medicare Billing by Year
| Year | Procedures | Beneficiaries | Services | Submitted | Medicare Paid |
|---|---|---|---|---|---|
| 2023 | 11 | 830 | 874 | $149,440 | $56,143 |
| 2022 | 12 | 1,004 | 1,070 | $179,065 | $75,804 |
| 2021 | 12 | 984 | 996 | $198,066 | $83,908 |
| 2020 | 16 | 1,087 | 1,190 | $215,886 | $71,639 |
All Medicare Procedures & Services
51 procedure records from CMS Medicare Utilization — Page 2 of 3
| HCPCS | Description | Setting | Year | Patients | Services | Charges | Medicare Paid | Ratio |
|---|---|---|---|---|---|---|---|---|
| 99203 | New patient outpatient visit, total time 30-44 minutes | Office | 2021 | 110 | 110 | $34,033 | $13,981 | 41.1% |
| 99204 | New patient outpatient visit, total time 45-59 minutes | Office | 2021 | 71 | 71 | $33,809 | $13,848 | 41.0% |
| 87426 | Elisa detection of severe acute respiratory syndrome coronavirus 2 (covid-19) antigen | Office | 2021 | 352 | 358 | $35,800 | $12,613 | 35.2% |
| 99212 | Established patient outpatient visit, total time 10-19 minutes | Office | 2021 | 30 | 30 | $3,914 | $1,967 | 50.3% |
| 99202 | New patient outpatient visit, total time 15-29 minutes | Office | 2021 | 15 | 15 | $3,150 | $1,341 | 42.6% |
| 71046 | X-ray of chest, 2 views | Office | 2021 | 20 | 20 | $2,201 | $597.42 | 27.1% |
| 87880 | Strep test by immunoassay for streptococcus | Office | 2021 | 14 | 14 | $776.00 | $231.42 | 29.8% |
| 36415 | Insertion of needle into vein for collection of blood sample | Office | 2021 | 19 | 19 | $313.75 | $57.00 | 18.2% |
| 81003 | Automated urinalysis test | Office | 2021 | 22 | 22 | $426.73 | $49.50 | 11.6% |
| 81002 | Urinalysis, manual test | Office | 2021 | 12 | 12 | $108.00 | $41.76 | 38.7% |
| 99213 | Established patient office or other outpatient visit, typically 15 minutes | Office | 2020 | 276 | 300 | $64,570 | $21,266 | 32.9% |
| 99214 | Established patient office or other outpatient, visit typically 25 minutes | Office | 2020 | 150 | 164 | $51,513 | $17,112 | 33.2% |
| 99203 | New patient office or other outpatient visit, typically 30 minutes | Office | 2020 | 94 | 94 | $30,377 | $10,149 | 33.4% |
| 99204 | New patient office or other outpatient visit, typically 45 minutes | Office | 2020 | 41 | 41 | $19,964 | $6,771 | 33.9% |
| 87426 | Coronavirus ag ia | Office | 2020 | 116 | 122 | $12,200 | $4,310 | 35.3% |
| 99202 | New patient office or other outpatient visit, typically 20 minutes | Office | 2020 | 40 | 40 | $8,839 | $3,648 | 41.3% |
| 99212 | Established patient office or other outpatient visit, typically 10 minutes | Office | 2020 | 67 | 69 | $8,940 | $3,546 | 39.7% |
| 87804 | Detection test for influenza virus | Office | 2020 | 47 | 94 | $6,879 | $1,529 | 22.2% |
| 71046 | X-ray of chest, 2 views | Office | 2020 | 37 | 39 | $4,293 | $1,150 | 26.8% |
| 90662 | Vaccine for influenza for injection into muscle | Office | 2020 | 16 | 16 | $793.00 | $792.00 | 99.9% |
| 87880 | Strep test (streptococcus, group a) | Office | 2020 | 26 | 26 | $1,937 | $424.83 | 21.9% |
| 36415 | Insertion of needle into vein for collection of blood sample | Office | 2020 | 87 | 89 | $1,680 | $266.10 | 15.8% |
| 90714 | Vaccine for tetanus and diphtheria toxoids injection into muscle, patient 7 years or older | Office | 2020 | 13 | 13 | $1,776 | $250.54 | 14.1% |
| 90471 | Administration of 1 vaccine | Office | 2020 | 14 | 14 | $984.05 | $177.89 | 18.1% |
| G0008 | Administration of influenza virus vaccine | Office | 2020 | 17 | 17 | $142.00 | $131.22 | 92.4% |
About Dr. John Shallat, MD
Dr. John Shallat, MD is a Emergency Medicine healthcare provider based in Deer Park, New York. This provider has been registered with the National Plan and Provider Enumeration System (NPPES) since 05/22/2007. The National Provider Identifier (NPI) number assigned to this provider is 1538379599.
According to the Centers for Medicare & Medicaid Services (CMS) Open Payments database, Dr. John Shallat, MD has received a total of $43.33 in payments from pharmaceutical and medical device companies, with $43.33 received in 2017. These payments were reported across 3 transactions from 2 companies. The most common payment nature is "Food and Beverage" ($43.33).
As a Medicare-enrolled provider, Shallat has provided services to 3,905 Medicare beneficiaries, totaling 4,130 services with total Medicare billing of $287,493. Data is available for 4 years (2020–2023), covering 51 distinct procedure/service records.
Practice Information
- Specialty Emergency Medicine
- Location Deer Park, NY
- Active Since 05/22/2007
- Last Updated 12/06/2019
- Taxonomy Code 207P00000X
- Entity Type Individual
- Practice Solo Practitioner
- NPI Number 1538379599
Products in Payments
- PROAIR (Drug) $26.06
- SUBOXONE SUBLINGUAL FILM (Drug) $17.27
Explore
Data Sources
Provider data from NPPES. Payment data from CMS Open Payments. Medicare data from CMS Medicare Provider Utilization. All data is public and updated periodically.